|
Bill focuses on enterprise companies and technologies for Greylock, a private equity venture capital firm founded in 1965. Having joined Greylock in 1984, Mr. Helman serves in the role of general partner. Bill also led Greylock’s investments in Exact Sciences (EXAS), Tessera (merged with iXL), Ontogeny, Hyperion Software, Filene’s Basement, Pharmacopeia (PCOP), Millennium Pharmaceuticals (MLNM), Staples.com (acquired by Staples), and Vertex Pharmaceuticals (VRTX). In addition to representing Greylock on the Board of Directors for CentrePath, he also is a member of the Board for Incipient, iPhrase, netNumina, OATSystems, OutlookSoft, Reveal, Upromise, and Vettro. He is a graduate of Dartmouth College and the Harvard Business School. | 